↓ Skip to Main Content
  • Home
  • Site Map
Vichem
  • About us
    • Vision & Mission
    • CEO
    • Strategic alliances
    • Partners
    • Top publications
    • Patent applications
  • Services
    • Fluorescent labeling of small molecules
    • Synthetic chemistry services for target identification
    • Custom synthesis
    • Contract research
    • Hit finding, assay development & screening
    • Hit to lead optimization, patentable lead generation
    • Process development & optimization
    • Liquid handling & sample management
    • Analytical Services
  • Compound libraries
    • Building blocks
    • Artemisinin derivatives
    • Nested Chemical Library™ (NCL)
    • Allosteric Library (AL)
    • Tool Compound Libary (TCL)
  • R&D projects
    • Myeloma and solid tumors
    • Development of selective FLT3 inhibitors
    • HIV
    • Other Projects
  • NRDI grants
    • TÉT_13_DST
    • KMR_12
  • EC grants
  • Pipeline
  • Contact us
Menu
Home › Site Map

Site Map

Categories

  • No categories

Latest Posts

Pages

  • Analytical Services
  • Artemisinin derivatives
  • CEO
  • Contact us
  • Contract research
  • Custom synthesis
  • EU Grants
  • Fluorescent labeling of small molecules
  • Hit finding, assay development & screening
  • Hit to lead optimization, patentable lead generation
  • Home
  • Liquid handling & sample management
  • Magyarország megújul
  • Myeloma and solid tumors
  • NEOVASCULOSTOP
  • Partners
  • Patents invented by our scientists
  • PI3K-AKT-mTOR pathway inhibitors
  • Process development & optimization
  • Projects
  • R&D projects
  • Scientific advisory board
  • Services
  • Site Map
  • Strategic alliances
  • Synthetic chemistry services for target identification
  • testmp3
  • testmp4
  • Top publications
  • Új tuberkulózis ellenes gyógyszerek fejlesztése indult a Nemzeti Kutatási, Fejlesztési és Innovációs Hivatal támogatásával (TÉT_13_DST-1-2013-0012)
  • VCC905240
  • Vichem pipeline
  • Vision & Mission
  • Nested Chemical Library™ (NCL)
  • DriverHit Library® (DHL)
  • HIV
  • Allosteric Library (AL)
  • Development of selective FLT3 inhibitors
  • Tool Compound Libary (TCL)
  • Kinase inhibitor building blocks
    © 2023 Vichem
    ↑
    The Kinase Inhibitor Company